rs370441301
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 5P and 1B. PS1_ModeratePM2PP5BP4
The NM_000081.4(LYST):c.5719A>G(p.Ile1907Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000268 in 1,607,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.
Frequency
Consequence
NM_000081.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251016Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135678
GnomAD4 exome AF: 0.0000241 AC: 35AN: 1454796Hom.: 0 Cov.: 28 AF XY: 0.0000318 AC XY: 23AN XY: 724164
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74396
ClinVar
Submissions by phenotype
Chédiak-Higashi syndrome Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 31, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1907 of the LYST protein (p.Ile1907Val). This variant is present in population databases (rs370441301, gnomAD 0.006%). This missense change has been observed in individual(s) with Chediak Higashi-syndrome (PMID: 31906877). ClinVar contains an entry for this variant (Variation ID: 561992). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LYST protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Fan Lab, Zhengzhou University | Apr 23, 2018 | This missense variant was inherited from the patient's mother (c.5719A>G, p.Ile1907Val). Typical clinical features of Chediak-Higashi Syndrome were observed in the patient, including decreased pigmentation of skin and hair, neutropenia, peculiar malignant lymphoma. Functional prediction showed loss of protein function caused by the peptide change. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant p.I1907V in LYST (NM_000081.4) has been reported previously as a disease causing mutation in compound heterozygous state with a splice site mutation (Song Y et al). Functional studies via ELISA had proved loss of protein expression. The variant has been submitted to ClinVar with varying interpretations of pathogenicity- VUS/Likely Pathogenic. The p.I1907V variant is observed in 2/30,606 (0.0065%) alleles from individuals of South Asian background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.I1907V missense variant is predicted to be tolerated by both SIFT or PolyPhen2. The valine residue at codon 1907 of LYST is present in Opossum and 2 other mammalian species. For these reasons, this variant has been classified as Likely Pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 02, 2023 | BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at